STRIVERDI RESPIMAT 2.5mcg inhalation solution medication leaflet

R03AC19 olodaterol • Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists

Olodaterol is a long-acting beta-2 adrenergic agonist used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the smooth muscles of the airways, making breathing easier.

The medication is administered via an inhaler, usually once daily, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms.

Common side effects include tremors, palpitations, headaches, and dry mouth. In rare cases, severe reactions such as paradoxical bronchospasm or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about STRIVERDI RESPIMAT 2.5mcg

Substance: olodaterol

Date of last drug list: 01-07-2021

Commercial code: W60771007

Concentration: 2.5mcg

Pharmaceutical form: inhalation solution

Quantity: 3

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA

Holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA

Number: 11140/2018/04

Shelf life: 3 years-; after the first opening a cartusului - 3 months; dupa prima utilizare a inhalatorului- 1an

Combinations with other substances